Trial intelligence / Profile preview

Metronidazole Add-on to High Dose Dual Therapy for H. pylori Rescue

NCT04024527Phase 4Completed

Sponsor
Shanghai Jiao Tong University School of Medicine
Start
Jul 2019
Primary completion
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of metronidazole in Helicobacter pylori infection, sponsored by Shanghai Jiao Tong University School of Medicine. Started Jul 2019; status: completed.

02

Drugs

metronidazole
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT04024527.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04024527.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call